FDA Advisory Panel to Hold Meeting Today on COVID-19 Booster Shots
Advisory panel will review a variety of evidence, including new data from Israel
Most Highly Allergic People Can Be Safely Immunized Against COVID-19
Algorithm enables immunization of most individuals, with 0.7 percent developing anaphylactic reaction after one BNT162b2 dose
Individuals With COVID-19 Most Infectious Around Symptom Onset
Individuals are most infectious in the two days before and three days after symptom onset
Risk for Asthma at Age 4 Years Higher After Pneumonia in Infancy
Risk slightly higher after introduction of nationwide pneumococcal conjugate vaccine
Risk for Hospitalization, ED Use Up With SARS-CoV-2 Delta Variant
Risk increased for being admitted to the hospital or attending emergency care within 14 days with delta variant
42.4 Percent of U.S. Teens Have Received at Least One COVID-19 Shot
Vaccination coverages vary by state, with rates of one dose or more ranging from from 20.2 percent in Mississippi to 70.1 percent in Vermont
Burden of Hospital-Acquired SARS-CoV-2 Infection Estimated
Authors say that approximately one-tenth of patients with COVID-19 in U.K. hospitals were infected after admission
Vaccines’ Power Against COVID-19 Hospitalization Fades in Elderly
Hospitalization rates among fully vaccinated higher among older residents of nursing homes and among those with underlying conditions
Toxic Leaded Gasoline Is Finished Globally
Use of the fuel has been linked to a wide range of human health problems
Monoclonal Antibody Therapy May Cut COVID-19 Hospitalizations
Lower hospitalization rates seen at 14, 21, 28 days for high-risk patients with mild-to-moderate COVID-19 who received casirivimab-imdevimab
